Paclitaxel NDC 0703-3217

NDC codes

FDA NDC Directory

Product NDC (as listed)0703-3217Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00703-3217Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0703-3217-01	00703321701	1 VIAL, MULTI-DOSE in 1 CARTON (0703-3217-01) / 25 mL in 1 VIAL, MULTI-DOSEMarketed from Mar 5, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paclitaxel
Generic name (nonproprietary): paclitaxel
Active ingredients: Paclitaxel — 6 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Teva Parenteral Medicines, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075184
Marketing start: Mar 5, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 0703-3217_26567d69-d05c-44e5-b3ca-e4504aa3c8a6SPL ID 26567d69-d05c-44e5-b3ca-e4504aa3c8a6SPL set ID e4be6cbf-72b9-4f7f-9b1b-459b2d35961aRxCUI 312199UNII P88XT4IS4DUPC 0307033213019
Pharmacologic class: Microtubule Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400703321701 followed by a unit qualifier and the quantity

Package 00703-3217-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 075184

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075184
Product	Strength	Form · route	Labeler	Product NDC
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3218
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3213
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3213
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3216
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3216
Paclitaxel	Paclitaxel 6 mg/mL	Injection, Solution, ConcentrateIntravenous	Teva Parenteral Medicines, Inc.	0703-3218